Swiss National Bank’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Swiss National Bank’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-208,800	Closed	-$3.54M	–	2573
2014 Q4	$3.54M	Buy	208,800 +13,900	+7%	+$196K	0.01%	912
2014 Q3	$2.32M	Buy	194,900 +28,800	+17%	+$197K	0.01%	1105
2014 Q2	$937K	Buy	166,100 +5,200	+3%	+$24K	﹤0.01%	1756
2014 Q1	$591K	Buy	160,900 +34,400	+27%	+$131K	﹤0.01%	2040
2013 Q4	$425K	Hold	126,500	–	–	﹤0.01%	2089
2013 Q3	$536K	Buy	126,500 +8,500	+7%	+$40.3K	﹤0.01%	1895
2013 Q2	$543K	Buy	+118,000	New	+$406K	﹤0.01%	1856

Swiss National Bank's AVNR Position: Q1 2015 in Review

Swiss National Bank sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 208,800 shares — an estimated $3.54M sold.

Swiss National Bank first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $3.54M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Swiss National Bank reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Swiss National Bank sold 208,800 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $3.54M.
Swiss National Bank first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Swiss National Bank's AVANIR PHARMACEUTICALS, INC CL A position peaked at $3.54M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.